These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15895004)

  • 21. Screening for trisomy 21 during the routine second-trimester ultrasound examination in an unselected Chilean population.
    Parra-Cordero M; Quiroz L; Rencoret G; Pedraza D; Muñoz H; Soto-Chacón E; Miranda-Mendoza I
    Ultrasound Obstet Gynecol; 2007 Dec; 30(7):946-51. PubMed ID: 17987599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the second trimester genetic sonogram in screening for fetal Down syndrome.
    Benacerraf BR
    Semin Perinatol; 2005 Dec; 29(6):386-94. PubMed ID: 16533652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal ultrasound diagnosis of Down syndrome. After major malformations, soft markers, nuchal translucency and skeletal signs, a new vascular sign?
    Chaoui R
    Ultrasound Obstet Gynecol; 2005 Sep; 26(3):214-7. PubMed ID: 16116560
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of Down syndrome screening strategies.
    Wenstrom KD
    Semin Perinatol; 2005 Aug; 29(4):219-24. PubMed ID: 16104672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the genetic sonogram in the United States in 2001 and 2007.
    Fang YM; Benn P; Egan JF
    J Ultrasound Med; 2008 Nov; 27(11):1543-8. PubMed ID: 18946092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Between pregnancy biological variability of first trimester markers of Down syndrome: implications for screening in subsequent pregnancies.
    Spencer K
    Prenat Diagn; 2001 Jun; 21(6):445-7. PubMed ID: 11438946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome.
    Wald NJ; Hackshaw AK
    Prenat Diagn; 1997 Sep; 17(9):821-9. PubMed ID: 9316126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuchal fold and nasal bone: how should we use them in Down syndrome screening?
    Wapner RJ
    Am J Obstet Gynecol; 2008 Sep; 199(3):213-4. PubMed ID: 18771970
    [No Abstract]   [Full Text] [Related]  

  • 30. On the current dilemma of Down syndrome screening.
    Rose NC
    Obstet Gynecol; 2006 Jan; 107(1):2-3. PubMed ID: 16394031
    [No Abstract]   [Full Text] [Related]  

  • 31. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidental Fetal Ultrasound Findings: Interpretation and Management.
    Kaplan R; Adams S
    J Midwifery Womens Health; 2018 May; 63(3):323-329. PubMed ID: 29763964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down's syndrome screening with nuchal translucency.
    Hackshaw AK; Wald NJ; Haddow JE
    Lancet; 1996 Dec 21-28; 348(9043):1740. PubMed ID: 8973459
    [No Abstract]   [Full Text] [Related]  

  • 36. Prenatal sonographic findings in 207 fetuses with trisomy 21.
    Papp C; Bán Z; Szigeti Z; Csaba A; Lázár L; Nagy GR; Papp Z
    Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):186-90. PubMed ID: 17029755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuchal translucency measurement in first trimester Down syndrome screening.
    Scott A
    Issues Emerg Health Technol; 2007 Jun; (100):1-6. PubMed ID: 17595751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down syndrome screening in the first and second trimesters: what do the data show?
    Rosen T; D'Alton ME
    Semin Perinatol; 2005 Dec; 29(6):367-75. PubMed ID: 16533649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of the nuchal fold in the second trimester fetus.
    Benacerraf B
    Prenat Diagn; 2002 Sep; 22(9):798-801. PubMed ID: 12224074
    [No Abstract]   [Full Text] [Related]  

  • 40. Nuchal translucency measurement and second-trimester biochemical screening for Down's syndrome.
    Frohlich EP
    Ultrasound Obstet Gynecol; 1997 Sep; 10(3):221-2. PubMed ID: 9339533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.